CPhI Japan Moves to Spring 2021
Following a review, CPhI Japan has been postponed until April 14–16, 2021 to ensure positive business conditions and greater attendance.
Following a review, CPhI Japan has been postponed until April 14–16, 2021 to ensure positive business conditions and greater attendance, event organizers announced in a July 27, 2020 press release.
“We had been optimistic that the event could go ahead, and we know how important it is for the pharma market in Japan to have a tailored platform to meet international customers and industry professionals. Meeting in person is an essential part of business in Japan,” said Christopher Eve, senior vice-president, CPhI Japan at Informa Markets, in the press release. “However, the decision to postpone reflects the reality that many companies and governments still have uncertain and ongoing travel restrictions in place. We are committed to ensuring CPhI Japan 2021 is well worth the wait and look forward to welcoming global pharma back to Japan. Thank you to all of our key stakeholders for their continued support.”
The event will still be hosted at the Big Sight Exhibition Centre in Tokyo in 2021. Additionally, the organizers are planning a number of bespoke digital product offerings to enable industry meetings and offer forums where ideas can be shared later on in 2020. Details of the digital products will be available in due course.
Source: CPhI
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
